Previous close | 65.23 |
Open | 65.23 |
Bid | 69.30 |
Ask | 72.40 |
Strike | 65.00 |
Expiry date | 2022-05-20 |
Day's range | 65.23 - 65.23 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Vertex's (VRTX) cystic franchise sales continue to grow. Vertex has a broad clinical non-CF pipeline, which is progressing rapidly.
Yahoo Finance's Jared Blikre breaks down the stocks Warren Buffett's Berkshire Hathaway is buying and selling.
Pharma giant AbbVie (NYSE: ABBV) has rewarded shareholders in the past decade with market-beating performance. AbbVie's strong showing was primarily a result of its top-selling drug, Humira. If the company manages to replace the medicine, it could deliver many more years of solid performances.